Medigenix Health is a strategic consultancy for pharmaceutical and biotech companies — and an active in-licensing partner. Beyond advising, we in-license added-value products to build our own specialty portfolio, supporting every stage from pipeline mapping to production with speed to market and a P&L discipline.
Where-to-play and right-to-win analysis, target segments and customers, ATC and BCG portfolio prioritization, and pipeline creation built on a clear, fundable business model.
Sales-force design, call planning, territory and stock-level optimization, demand creation at the customer level, and P&L-driven commercial execution.
CLM-based content tailored to customer needs, KOL engagement, closed-loop detailing, and digital platform management across the customer journey.
Asset and portfolio valuation, commercial and scientific due diligence, global in- and out-licensing, partnerships with global licensors, and EU-GMP CDMO/CMO manufacturing partnerships.
Beyond consulting, Medigenix actively seeks to in-license added-value products in Oncology, Dermatology, Central Nervous System diseases, Diabetes & Obesity, Endocrinology-related diseases, Respiratory diseases, Haematology, and Immune-system diseases including Rheumatoid Arthritis and other immune-related conditions.